Failed cancer vaccines might live again with new immune drugs
Using vaccines to fight cancer is a field littered with failures, but experts believe it is possible the approach could get a new lease on life if such shots are combined with a new class of drugs called checkpoint inhibitors. Unlike traditional preventative vaccines, therapeutic cancer vaccines are designed for people with established disease and are supposed to boost the patient's immune system to keep tumors at bay.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063